Novavax Inc

Type: Company

Name: Novavax Inc

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Will Influenza A H7N9 Generate Opportunities For Pharma?

It has been hard not to hear about the H7N9 flu virus. Everybody bears in mind the H1N1 scandal. Briefly, the H1N1 virus quickly received an exaggerated status, in a first time, by media, and in a second time, by World Health Organization (WHO). The since ... [Published Seeking Alpha - May 21 2013]

Entities: Influenza, H7N9, Virus, Pandemic

First reported May 21 2013 - Updated May 21 2013 - 1 reports

OxiGene Inc

Flexion Therapeutics inc elects Frederick Driscoll as CFO

Specialist pharmaceutical company Flexion Therapeutics Inc revealed on Monday the appointment of Frederick W Driscoll as its chief financial officer. Most recently, Driscoll has served as chief financial officer for Novavax (NasdaqGS:NVAX), where he led ... [Published Individual.com - May 21 2013]

Entities: Flexion Ltd, Therapeutics, Elections, OxiGene Inc, Novavax Inc

First reported May 20 2013 - Updated May 20 2013 - 1 reports

The RSV A nanoparticle vaccine: clinical update – Dr Gregory M. Glenn

World Vaccine Congress & Expo 2013Dr. Gregory M. Glenn, Senior VP of CMO at Novavax gives his presentation on ‘The RSV A nanoparticle vaccine: clinical update’.The World Vaccine Congress & Expo is now in its 13th year and is the biggest and most comprehensive ... [Published Terrapinn - May 20 2013]

Entities: Vaccine, Nanoparticle, Novavax Inc, Research & Development

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer

Flexion Therapeutics, Inc. today announced the addition of Frederick W. Driscoll to its management team as chief financial officer. Mr. Driscoll has more than 30 years of financial management experience with biotechnology and medical device companies ... [Published Zecco - May 20 2013]

Entities: Flexion Ltd, Therapeutics, Novavax Inc, Osteoarthritis

First reported May 19 2013 - Updated May 19 2013 - 1 reports

Aegerion Pharmaceuticals Inc

The Best- And Worst- Performing Biotech Stocks, May 10 To May 17

These are the best and worst-performing medical and biotech stocks from May 10 to May 17, 2013. This screen includes biotechnology and medical companies traded on the New York Stock Exchange, the Nasdaq or the American Stock Exchange that had market capitalizations ... [Published Forbes.com - May 19 2013]

Entities: Biotechnology, Stocks, Aegerion Pharmaceuticals Inc

First reported May 10 2013 - Updated May 11 2013 - 4 reports

Novavax, Inc. (NVAX) H7N9 VLP Influenza Vaccine Enters Animal Testing

Staying up-to-date has never been simpler. Sign up for the today! ROCKVILLE, Md., May 10, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it has completed purification of a lot of A/Anhui/1/13 H7N9 virus-like particle (VLP) vaccine ... [Published BioSpace - May 11 2013]

Entities: Novavax Inc, H7N9, Vaccine, ImmunoGen Inc, Recombinant

First reported May 07 2013 - Updated May 08 2013 - 3 reports

Novavax's CEO Discusses Q1 2013 Results - Earnings Call Transcript

10:00 AM ETOperatorOperator: Good day ladies and gentlemen and welcome to the Novavax, Inc., First Quarter 2013 Earnings Conference Call. At this time all participants are in a listen-only mode. Later, we’ll have a question-and-answer session and instructions ... [Published Seeking Alpha - May 08 2013]

Entities: Novavax Inc, Vaccine, Clinical trials, Pandemic, adjuvant

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Novavax, Inc. (NVAX) Misses Q1 EPS by 1c

Novavax, Inc. (NASDAQ: NVAX) reported Q1 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $3.8 million versus the consensus estimate of $5.54 million.Research and development expenses increased to $9.4 ... [Published Street Insider - May 07 2013]

Entities: Novavax Inc, Administrative Expenses, Clinical trials, Research & Development

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Novavax Reports First-Quarter 2013 Financial Results

CONTACT: Frederick W. DriscollVP, Chief Financial Officer and TreasurerNovavax, Inc.240-268-2 ... [Published Reuters - May 07 2013]

Entities: Novavax Inc

First reported May 03 2013 - Updated May 03 2013 - 3 reports

China's H7N9 Bird Flu And Novavax

Home » Blogs » On March 31, 2013, the Chinese Government confirmed the presence of a new strain of bird flu, that being H7N9. Since that time, and as of the date of writing this article, there have been 127 confirmed cases resulting in 27 deaths. The ... [Published BioPortfolio - May 03 2013]

Entities: Novavax Inc, H7N9, Bird Flu

First reported Apr 26 2013 - Updated Apr 26 2013 - 1 reports

Form 4 NOVAVAX INC For: Apr 24 Filed by: EVANS GARY C

StreetInsider.com - Form 4 NOVAVAX INC For: Apr 24 Filed by: EVANS GARY C ... [Published Street Insider - Apr 26 2013]

Entities: Novavax Inc

First reported Apr 25 2013 - Updated Apr 25 2013 - 2 reports

Novavax to Present at 12th Annual Needham Healthcare Conference

CONTACT: Frederick W. DriscollVP, Chief Financial Officer and TreasurerNovavax, Inc.240-268-2 ... [Published Reuters - Apr 25 2013]

Entities: Novavax Inc, Healthcare Conference

Quotes

...While I highly recommend you to read Kyle's article, I strongly disagree with his following statement : "Even if China were to throw itself completely into the mass production of a vaccine, right now, it wouldn't be available to the general populace until 2015 at the earliest." The vaccine against H1N1 hit the market the year of H1N1 outbreak...

Will Influenza A H7N9 Generate Opportunities For Pharma? [Published Seeking Alpha - May 21 2013]

More From BioPortfolio on "The RSV A nanoparticle vaccine: clinical update – Dr Gregory M Glenn"

The RSV A nanoparticle vaccine: clinical update – Dr Gregory M. Glenn [Published BioPortfolio - May 20 2013]

...our pipeline of sustained release, intra-articular osteoarthritis medicines," said Michael Clayman, M D , chief executive officer of Flexion. "With Phase 2b data for our lead compound on the horizon, we are confident that Fred will play an important role in the future of the company."

Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer [Published Zecco - May 20 2013]

...Gregory Glenn, Novavax Chief Medical Officer. "Based on our recent clinical trials with A/H5N1 vaccine that induced 100% seroprotection using low doses of an otherwise poorly immunogenic vaccine, we are optimistic that our A/H7N9 VLP may induce strong immune responses and perform well in animal efficacy testing."

Novavax Initiates Animal Testing of H7N9 Nanoparticle VLP Influenza Vaccine [Published Azonano - May 13 2013]

More Content

sort by: Date \| Relevance
Longtime Forest Labs CEO Howard Solomon steps a... [Published FierceBiotech - 20 hours ago]
Will Influenza A H7N9 Generate Opportunities Fo... [Published Seeking Alpha - May 21 2013]
Flexion Therapeutics inc elects Frederick Drisc... [Published Individual.com - May 21 2013]
The RSV A nanoparticle vaccine: clinical update... [Published Terrapinn - May 20 2013]
The RSV A nanoparticle vaccine: clinical update... [Published BioPortfolio - May 20 2013]
Flexion Therapeutics Names Frederick Driscoll C... [Published Zecco - May 20 2013]
The Best- And Worst- Performing Biotech Stocks,... [Published Forbes.com - May 19 2013]
Novavax, Inc. (NVAX) - Pharmaceuticals & Health... [Published TransWorldNews - May 18 2013]
Novavax Initiates Animal Testing of H7N9 Nanopa... [Published Azonano - May 13 2013]
Novavax, Inc. (NVAX) H7N9 VLP Influenza Vaccine... [Published BioSpace - May 11 2013]
Novavax, Inc. (NVAX) Initiates Animal Testing f... [Published StockHouse USA - May 10 2013]
Novavax, Inc. H7N9 VLP Influenza Vaccine Enters... [Published BioSpace - May 10 2013]
Novavax H7N9 VLP Influenza Vaccine Enters Anima... [Published GlobeNewswire: Acquisitions News - May 10 2013]
Novavax H7N9 VLP Influenza Vaccine Enters Anima... [Published Nasdaq - May 10 2013]
News Recap: TravelCenters of America, Quicksilv... [Published SBWire - May 08 2013]
Stock Losers: Novavax, Vitamin Shoppe Inc, Nort... [Published SBWire - May 08 2013]
Novavax's CEO Discusses Q1 2013 Results - Earni... [Published Seeking Alpha - May 08 2013]
U.S./Canada daily earnings hits & misses May 7 ... [Published Globe and Mail - May 07 2013]
U.S./Canada daily earnings hits & misses May 7 ... [Published Globe and Mail - May 07 2013]
Ogilvy CommonHealth Worldwide Recruits Amy Grah... [Published Market Wire - May 07 2013]
U.S./Canada daily earnings hits & misses May 7 ... [Published Globe and Mail - May 07 2013]
Novavax, Inc. (NVAX) Misses Q1 EPS by 1c [Published Street Insider - May 07 2013]
Novavax Reports First-Quarter 2013 Financial Re... [Published Reuters - May 07 2013]
Novavax Reports First-Quarter 2013 Financial Re... [Published Yahoo! Finance - May 07 2013]
Novavax Reports First-Quarter 2013 Financial Re... [Published GlobeNewswire: Acquisitions News - May 07 2013]
Novavax Reports First-Quarter 2013 Financial Re... [Published Individual.com - May 07 2013]
Novavax (NVAX): Q1 EPS of -$0.07 misses by $0.0... [Published Seeking Alpha - May 07 2013]
China's H7N9 Bird Flu And Novavax [Published BioPortfolio - May 03 2013]
China's H7N9 Bird Flu And Novavax [Published Zecco - May 03 2013]
China's H7N9 Bird Flu And Novavax [Published Healthcare Sector and Stocks Analysis from Seek ... - May 03 2013]

Blogs

sort by: Date \| Relevance
CORRECTED-UPDATE 1-New technology speeding prog... [Published AdBanks.net - Apr 13 2013] Fri Apr 12, 2013 7:09pm EDT (In 20th paragraph, corrects title of Mike Shaw to make clear he runs a CDC laboratory instead of being director of the CDC) * Faster DNA method shaved 2 weeks off vaccine process * Chinese researchers say counter ...
CORRECTED-RPT-New technology speeding progress ... [Published AdBanks.net - Apr 13 2013] Fri Apr 12, 2013 7:09pm EDT (In 20th paragraph, corrects title of Mike Shaw to make clear he runs a CDC laboratory instead of being director of the CDC) * Faster DNA method shaved 2 weeks off vaccine process * Chinese researchers say counter ...
4 Healthcare Stock Stories for Wednesday Invest... [Published Wall St. Cheat Sheet - Apr 03 2013] Novavax ( NASDAQ:NVAX ): Current price $2.35 The company has announced that top-line data from the Phase II dose-ranging clinical trial of its respiratory syncytial virus vaccine candidate in women of childbearing age, attained the trial’s protocol-specified ...
4 Healthcare Stock Stories Not To Be Overlooked [Published Wall St. Cheat Sheet - Mar 18 2013] AstraZeneca Group ( NYSE:AZN ): Closing price $46.18 The firm is poised to slash approximatey 1,600 jobs as it reconfigures its research operations and consolidates drug development work in three major centers in the United Kingdom, the United States ...
Suntech Defaults and 4 Other Hot Stocks [Published Wall St. Cheat Sheet - Mar 18 2013] General Motors ( NYSE:GM ) chairman and CEO Dan Akerson, along with lobbyist Selim Bingol, will meet with members of Congress in Washington on Thursday to apprise them personally “the GM story of a new company’s contribution to America’s economic ...

Press Releases

sort by: Date \| Relevance
Novavax H7N9 VLP Influenza Vaccine Enters Anima... [Published GlobeNewswire: Acquisitions News - May 10 2013]
Novavax Reports First-Quarter 2013 Financial Re... [Published GlobeNewswire: Acquisitions News - May 07 2013]
Novavax to Report First-Quarter 2013 Financial ... [Published GlobeNewswire: Advertising News - Apr 26 2013]
Novavax to Present at 12th Annual Needham Healt... [Published GlobeNewswire: Acquisitions News - Apr 25 2013]
MannKind, Ariad Pharma, Ziopharm Oncology, Gale... [Published Financial Services - Apr 23 2013]